한국어
English
日本語
中文(简体)
Jospata Tablets 40 mg (Gilteritinib Fumarate)
44.2mg
Tablet · Prescription medication
Astellas Pharma Korea Co., Ltd.
Gilteritinib fumarate is an anticancer agent used for the treatment of acute myeloid leukemia.
MFDS ingredient code M278276
Gilteritinib fumarate is a targeted anticancer agent used for the treatment of acute myeloid leukemia with specific genetic mutations. This agent selectively inhibits proteins involved in the growth and survival of cancer cells. It is primarily prescribed for patients with relapsed or refractory leukemia.
Gilteritinib fumarate works by blocking the activity of specific enzymes within cancer cells, thereby disrupting the signaling that allows cancer cells to proliferate and survive. This helps to suppress the growth of cancer cells and induce their death. It has relatively less impact on normal cells.
Approved uses differ by product. Check each product's information for its actual use.
Gilteritinib fumarate is a targeted therapy specifically for FLT3 gene mutations, acting on specific molecular targets unlike conventional anticancer agents. As a result, side effects may differ somewhat, and the treatment efficacy may vary depending on the mutation status.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.